In the complex aetiology of asthma, genetic and environmental mechanisms operate in concert. The remarkable increases in prevalence of allergic respiratory diseases over the past 20-30 yearsl 2, and differences between communities with similar genetic make-up3'4, indicate the importance of environmental factors. Ten years ago Strachans proposed that the increase in prevalence of atopic disease in westernized communities might be due to improved hygiene and hence fewer childhood infections. There is, however, the opposing argument that some childhood viral infections are strongly associated with the later development of recurrent wheeze and atopy in childhood6; thus, viral infection in early childhood may promote the development of recurrent wheezing in later life. In this editorial we suggest mechanisms whereby infections can both promote and prevent the establishment of asthma under different circumstances. Although changes in exposure to respiratory irritants, allergens or diet are undoubtedly important causes of the increased prevalence, here we focus on the role of infection.
A CAUSAL ROLE FOR INFECTIONS IN THE PATHOGENESIS OF ASTHMA
Respiratory viruses are now considered the most important triggers for acute exacerbation of established asthma7. Exacerbation is thought to be caused by altered cytokine responses in asthmatics, reflected by prolonged eosinophil accumulation in the lungs following viral infection8 and enhanced penetration of inhaled allergens during virusinduced lung inflammation9.
Both clinical and laboratory data suggest an additional causal link between bronchiolitis and asthma. Sigurs6 reported 47 infants admitted to hospital with respiratory syncytial virus (RSV) bronchiolitis at a mean age of 3.5 months. Of these, 23% were diagnosed with asthma in the 3 ensuing years, compared with 1% of controls. A positive test for serum IgE antibodies was found in 32% of the bronchiolitics compared with 9% of controls. An association between infantile bronchiolitis and the diagnosis of asthma was also found by Sly10 in 92% of 48 patients followed up prospectively for 5 years. Murray1I reported wheezing in 43% of children previously admitted to hospital with infantile bronchiolitis compared with 15% of controls, in a study of 73 children followed up for 5.5 years. Respiratory symptoms may persist for 8-13 years in children after RSV bronchiolitis12, and histamine responsiveness demonstrates hyperreactivity 10 years or more after the event13. Although these studies may point to a causal link between RSV bronchiolitis and asthma, the possibility of a genetic predisposition to both asthma and bronchiolitis can not be ruled out.
Work in animals supports a causal link between viral bronchiolitis and asthma. Brown Norway rats develop chronic, episodic and reversible airway obstruction after bronchiolitisI4. A predominant CD4+ T cell response with reduced interferon-gamma (IFN-y) production is seen, leading to airway remodelling with persistent inflammation, fibrosis and deposition of extracellular matrix material. A mouse model of RSV bronchiolitis demonstrates a T helper 2 (Th2) cell predominance in response to the major surface glycoprotein G of RSV in certain mouse strains15. This is in contrast to the usual T helper 1 (Thl) response seen in most primary viral infections, leading to prominent lung eosinophilia after RSV challenge. This response is linked to the inability of the G-protein to stimulate CD8+ T cells, emphasizing the important non-cytolytic role of CD8+ cells. CD8+ T cells also exhibit type 1 and type 2 cytokine production patterns (Tcl and Tc2, respectively) and may have an important role in determining CD4 phenotypes16.
When individuals are exposed to respiratory viruses and allergens simultaneously, interactions have been reported that could lead to the establishment of asthma. The combination of atopy and concurrent viral illness is a greater risk factor than any one of these factors alone in children presenting to an emergency room with acute airway obstruction17. Experimental rhinovirus-16 inoculation in individuals with allergic rhinitis alters their response to allergen bronchoprovocation to favour the development of the late-phase response18. This is associated with airway inflammation and hyperresponsiveness and suggests that viruses may induce the development of an asthmatic phenotype under specific conditions. Work in animals supports this concept. Uninfected mice develop no IgE antibody against inhaled antigen (ovalbumin), but during acute influenza infection sensitization does take place19. Neither influenza A virus nor ovalbumin alone causes changes in serum IgE or airway responsiveness to inhaled 0 [-' metacholine but both are increased when antigen exposure coincides with influenza infection20. O'Donnell observed acute systemic illness and collapse in response to cutaneous ovalbumin administration in mice previously exposed to concurrent RSV infection and nebulized ovalbumin, but not in animals exposed to either of these insults alone9. This suggests that viral inflammation allows inhaled antigen to penetrate the barrier of the respiratory mucosa, promoting sensitization.
Chronic Chlamydia pneumoniae infection has been linked to acute exacerbations of asthma21 but immune responses of patients with frequent exacerbations additionally suggest a role for Chlamydia in asthma pathogenesis. Cunningham investigated 108 children with asthma and found a tendency to remain polymerase-chain-reaction-positive for Chiamydia in those with frequent acute episodes, suggesting chronic infection. Previous chlamydial exposure has been demonstrated by Cook et al. in 34 .8% of patients with severe chronic asthma22 but other studies23 provided no evidence of chlamydial disease in asthmatics. Evidence of Mycoplasma pneumoniae infection has been found in the lower airways of stable asthmatics with greater frequency than in control subjects, suggesting a pathogenic role24. These issues require further investigation since most studies are small and there are many conflicting findings. As with the RSV data, a simultaneous genetic predisposition to both asthma and these infections cannot be ruled out.
The mechanisms by which viral and other infections during early life could affect later development of lung disease were summarized by Openshaw and Lemanske25. These include: (1) virus chronicity, persistence or latency;
(2) permanent changes to local anatomy; (3) impaired lung growth; (4) local foothold for other acute or chronic infections; (5) immunological tolerance; and (6) establishment of local immunological 'mood'. Sensitization to aeroallergens during respiratory infections can be added to this list.
THE POSSIBLE PROTECTIVE ROLE OF INFECTIONS IN THE ESTABLISHMENT OF ASTHMA
A protective role of early life infections in the development of atopy and asthma was suggested by British cohort studies conducted since 1958. A consistent relationship was found between birth order and the risk of atopy, the presence of older siblings appearing to protect younger children26'27'28. In 1989, Strachan29 reported that repeated infections in early life might prevent hayfever. The increase in atopic disease in developed countries was ascribed to the decreased cross-infection rates due to decreased family size29, now often referred to as the hygiene effect. Bodner et al. reported data obtained from a 1964 cross-sectional survey of Aberdeen schoolchildren. Although they too found the protective effect of large sibships, a higher number of infections before the age of three years was associated with a significant trend in odds ratios towards an increased risk of asthma. Remarkably, measles after the age of three protected against asthma, but chickenpox increased the risk and rubella was associated with eczema30. Working in Tucson, Arizona, Martinez examined the relations of lower respiratory tract illnesses (LRIs) in the first three years of life to atopy and serum IgE levels. Non-wheezing LRIs were associated with lower IgE levels and lower skin test reactivity than wheezing LRIs and absent LRIs. At the age of nine months, children with non-wheezing LRIs had higher IFN-y production from mononuclear cells than the other groups. Martinez argues that the immune response to viral infections in these children leads to selection ofThl cells with suppression of Th2 cells31. Von Mutius et al. conducted surveys soon after the reunification of East and West Germany, and showed a higher frequency of respiratory symptoms in the East German children (42% versus 27%), but a lower prevalence of asthma (3.8% versus 5.4%)32. These findings have been used to support the argument that respiratory infections protect against asthma, but there are several alternative interpretations. A high percentage of children in East Germany were diagnosed as having wheezy bronchitis, perhaps reflecting different definitions in the two regions. Furthermore, the same skin test antigens may not be appropriate in the two regions. Others have not been able to confirm the sibship effect. Farooqi and Hopkins33 found maternal atopy, antibiotic use in the first two years of life and administration of whole-cell pertussis vaccine to be predictors of atopy in their retrospective study of 1934 individuals from a 1974-1984 birth group at a family doctor practice. They found no association for sibship size. Another interesting observation relates to the high prevalence of asthma not only in developed communities but also in African cities4 and amongst low-income minority groups in the USA34. It is unlikely that poor urban children in Africa are subjected to less crowding and therefore experience less infection than their rural counterparts.
Another important study was recently reported by Shirakawa and co-workers in Japan35. In a BCG-vaccinated population, strong tuberculin responders were one-half to one-third as likely as non-responders to have asthma symptoms, and remission of asthma symptoms during childhood was six to nine times more likely. Serum IgE and Th2 cytokine levels were lower, but Thl cytokines higher, in strong responders. Shirakawa et al. argue that this reflects a causal link and not a fixed determination of both atopy and tuberculin response by genetic factors since the tuberculin response changed from positive to negative in some individuals and vice versa. There has been a marked decline in positive tuberculin responders over 20 years in the area, 35 coinciding with a decline in clinical tuberculosis cases .
A study from Guinea-Bissau showed that children who had previously had measles were less likely to develop atopy than children who had been vaccinated against measles36. The protective effect of measles was also supported by the Aberdeen study30 but here there was no effect or even a positive correlation with other childhood infections and atopy. This is surprising since crowding and sibship size should have the same effect on the transmission of these infections as on measles. The other infection that has been linked to a protective effect is hepatitis A37, which is transmitted via the faecal-oral route; this would support the hygiene hypothesis.
What are the proposed immunological mechanisms for the protective effect of infections in the development of atopic disease? Atopy is related to the expression of allergen-specific responses with production of Th2 cytokines such as IL-4 and IL-5, which promote IgE production and eosinophilia38. In non-atopic individuals, the T cell system is biased to a Thl phenotype with production of IFN-y and inhibition of Th2 cells. Further knowledge of the development of allergen-specific T cell memory is important for the possible primary prevention of allergic disease. The existence of fetally-derived allergen-reactive T cells exhibiting a Th2 phenotype indicates intrauterine T cell priming39. Prescott offers interesting support to the data on antibiotic use during the first two years of life as a risk factor for the development of atopy33.
The immunological basis of the hygiene hypothesis can be summarized as follows (Figure 1 ). Genetically predisposed individuals are born with allergen-specific T cells exhibiting a Th2 phenotype. Immunomodulatory microorganisms such as intracellular bacteria or viruses induce macrophages and dendritic cells to produce IL-12, which induces natural killer cells and Thl cells to produce IFN-y. IFN-y provides the environment for the differentiation of antigen-specific CD4+ T cells into Thl cells and CD8+ T cells into Tcl cells with even higher IFN-y production. In the absence of such early stimuli, the Th2-biased immature immune system persists and the allergen-specific responses become established to express an atopic phenotype. CONCLUSION There is good evidence that interactions with some respiratory viruses, particularly RSV, are followed by an increase in pulmonary symptoms. This association remains for at least 10 years and childhood acute respiratory illness may even be associated with respiratory morbidity and mortality in adult life45. Although respiratory infections have not conclusively been causally linked to later atopic disease, strong evidence from animal studies makes this highly plausible.
There is equally good evidence that exposure to an antigenically rich environment helps the immune system to mature from a Th2 cytokine profile at birth to a Thi cytokine profile during later childhood. This maturation may be slow and inefficient in children predisposed to atopy40 and may be promoted by repeated exposure to ingested and inhaled bacteria and by some childhood viral infections. Changes in these parameters may, in part, account for the recent rise in atopic diseases and asthma in the developed world. The effects of infectious agents on the development of allergy and atopy are not simple: infections may be protective in some individuals and yet promote long-term symptoms in others. To adopt polar views in the debate about the benefit and harm caused by childhood infections is inappropriate, since there are evident truths on both sides.
